FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to a preparation for drug hypersensitivity correction in integrated therapy of pulmonary tuberculosis. Application of biologically active substances with antimicrobial activity recovered from Pleurotus 1137 fungus mycelium (Russian National Collection of Industrial Microorganisms, F-819), as a preparation for drug hypersensitivity correction in integrated therapy of pulmonary tuberculosis.
EFFECT: biologically active substances recovered from fungus mycelium effectively reduce development of side reactions of antituberculous preparations.
2 cl, 17 tbl, 12 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS IN THE TREATMENT OF RESPIRATORY TUBERCULOSIS IN CHILDREN FROM FOCI WITH MULTIDRUG RESISTANCE OF THE PATHOGEN | 2022 |
|
RU2784464C1 |
METHOD FOR TREATING PATIENTS FOR PULMONARY TUBERCULOSIS | 2007 |
|
RU2318515C1 |
METHOD FOR THE TREATMENT OF RESPIRATORY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN THE EVENT OF ADVERSE REACTIONS | 2021 |
|
RU2772058C1 |
METHOD OF TREATMENT OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2323739C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
METHOD FOR REDUCING ADVERSE SIDE EFFECTS IN TREATING FOR TUBERCULOSIS | 2006 |
|
RU2314113C2 |
METHOD FOR TREATMENT OF PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2347575C1 |
METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2521197C1 |
METHOD OF TREATING DRUG-INDUCED LIVER INJURY IN CHILDREN SUFFERING FROM TUBERCULOSIS | 2011 |
|
RU2473346C1 |
Authors
Dates
2011-12-10—Published
2010-08-23—Filed